DUBLIN, December 12, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/mwvkcf/dry_powder) has announced the addition of the "Dry Powder Inhalers to 2020" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions - aliments that require frequent drug administration for a protracted period of time.
While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalation (DPI) as a formidable challenger to more established pulmonary methods such as metered dose inhalers and nebulizers. The past two years has seen an increase in DPI product introductions, with four new combination products receiving marketing approval.
While evolving DPI technology and combination therapeutic products continue to have a significant impact on the treatment of upper respiratory diseases and conditions, dry powder inhalers are making strides in applications requiring the systemic delivery of both small and large molecule and engineered macromolecules for the treatment of a range of pathologies.
Highlights
- Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products
- Examines Dry Powder Inhaler design issues and evolving market factors
- Forecasts the impact of DPI technology and devices on drug delivery markets and projects probable future developments
- Provides forecasts of DPI combination product demand by indication and drug class to 2020
- Profiles Dry Powder Inhalation market participants, their technology, product development activity, and business strategies
Key Topics Covered:
Executive Summary
The DPI Market in 2014
- Devices, Formulations and Market Evolution
- Established Therapeutic Targets
- Emerging Therapies
- Demographics and Growth
- Competing Technologies
- Market Drivers
- Risk Factors
Dry Powder Inhalation Technology
- Dry Powder Formulations
- Dry Powder Particle Technology & Powder Engineering
- Dry Powder Processing
- Dry Powder Packaging
- Emerging Formulations
- Dry Powder Inhalers
- DPI Device Characteristics
- DPI Design Parameters
Commercial DPI Device Design Factors
- Dose Form and Capacity
- Dose Variability
- Dispersion Technologies
- Activation
- Electronics and Patient-friendly Features
DPI Device Assessments and Analysis
- Bulk Reservoir Designs
- Blister Pack/Cartridge Designs
- Drug Capsule Designs
- Fixed Substrate Designs
- Emerging Device Designs
Therapeutic Market Analysis, Market Data and Forecasts
- Upper Respiratory
- Asthma
- COPD
- Systemic
- Bioterror
- Diabetes
- Hereditary Diseases
- Cystic Fibrosis
- Infectious Diseases
- Osteoporosis
- Neurology
- Pain Management
Market Factors
- Regulatory Initiatives
- Clinical Trial Endpoints
- Proprietary Technology
Company Profiles
For more information visit http://www.researchandmarkets.com/research/mwvkcf/dry_powder
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
